1035449-31-0Relevant academic research and scientific papers
Carbamoylphosphonate matrix metalloproteinase inhibitors 6: cis-2-aminocyclohexylcarbamoylphosphonic acid, a novel orally active antimetastatic matrix metalloproteinase-2 selective inhibitor-synthesis and pharmacodynamic and pharmacokinetic analysis
Hoffman, Amnon,Qadri, Bashir,Frant, Julia,Katz, Yiffat,Bhusare, Sudhakar R.,Breuer, Eli,Hadar, Rivka,Reich, Reuven
, p. 1406 - 1414 (2008)
cis-2-Aminocyclohexylcarbamoylphosphonic acid (cis-ACCP) was evaluated in vitro and in two in vivo cancer metastasis models. It reduced metastasis formation in mice by ~90% when administered by a repetitive once daily dosing regimen of 50 mg/kg via oral o
Electrochemically driven P-H oxidation and functionalization: Synthesis of carbamoylphosphonates from phosphoramides and alcohols
Wu, Qiu-Li,Chen, Xing-Guo,Huo, Cong-De,Wang, Xi-Cun,Quan, Zheng-Jun
, p. 1531 - 1535 (2019)
An electrochemical method to achieve carbamoylphosphonates from phosphoramides and alcohols via P-H oxidation and functionalization by using n-Bu4NI as a catalyst is reported. A series of carbamoylphosphonates were obtained with good to excellent yields under mild reaction conditions. The electrochemical reaction is carried out under constant current electrolysis, with the alcohol being used as a solvent and a substrate, and is an attractive green synthesis method.
NEW CARBAMOYL-AND THIOCARBAMOYL-PHOSPHONATES AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM
-
Page 19-20, (2010/02/09)
The present invention provides a compound of the following formula (I): R3-NH-C(=X)-P(=O)OR1OR2including pharmaceutically acceptable salts, solvates, hydrates and polymorphs of the compounds of formula I, as well as geo
